The translational potential of these platforms is reinforced by the clinical advancement of lipid nanoparticle (LNP) technologies, several of which have progressed to human trials for indications such as hypercholesterolemia, through PCSK9 silencing, and infectious diseases, including COVID-19 vaccines [429, 430]
This is why peptides are able to help generate elastin in collagen deep within skin tissues
Other studies have shown that PA improved hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway, which indicated that PA showed potential as a functional food therapeutic for the treatment of obesity (Xu et al., 2021)
Moreover, interventions that act on two or three ferroptosis pathways may increase the likelihood of therapeutic success
Clinical data has indicated that fiber increases post-meal GLP-1 secretion as well